{"id":"W2162451701","doi":"10.2217/imt.14.7","title":"Alemtuzumab for the Treatment of Relapsing–Remitting Multiple Sclerosis","year":2014,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Alemtuzumab; Relapsing remitting; Multiple sclerosis; Medicine; Fingolimod; Oncology; Internal medicine; Immunology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006104832,0.0005698335,0.002852321,0.0001852106,0.0003172451,0.00003577683,0.0003491071,0.0002654574,0.0000511058],"category_scores_gemma":[0.000485123,0.0002969566,0.001835264,0.0002692473,0.000277318,0.00002989073,0.00003663157,0.0002342736,0.00002587335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004836104,"about_ca_system_score_gemma":0.0002564972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001628864,"about_ca_topic_score_gemma":0.00001512597,"domain_scores_codex":[0.9973857,0.0001799426,0.001000417,0.0004816127,0.0004299868,0.0005223088],"domain_scores_gemma":[0.9931188,0.00475002,0.000611446,0.001215886,0.0002323151,0.00007149759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001809581,0.0003067446,0.0000295662,0.005078903,0.002364182,4.348669e-7,0.0004046128,7.921209e-7,0.0001418029,0.00001432344,0.0005499696,0.9909277],"study_design_scores_gemma":[0.003823374,0.001310826,0.000173214,0.01416341,0.0008304513,0.000007098681,0.00004613727,0.000147319,0.00007632717,0.000002706918,0.9791914,0.0002277892],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005149272,0.9935478,0.0005305022,0.0001529923,0.0003558077,0.005063661,0.0001108887,0.00006070821,0.0001261639],"genre_scores_gemma":[0.0001001873,0.9943106,0.001684541,0.00004629347,0.0005423565,0.001998822,0.00007864535,0.0001636196,0.001074958],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9906999,"threshold_uncertainty_score":0.9999483,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2022904802481968,"score_gpt":0.4048349850202537,"score_spread":0.2025445047720569,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}